Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (22)
Marissa Mock, Alex W. Jacobitz, Christopher James Langmead, Athena Sudom, Daniel Yoo, Sara C. Humphreys, Mai Alday, Larysa Alekseychyk, Nicolas Angell, Vivian Bi, Hannah Catterall, Chen-Chun Chen, Hui-Ting Chou, Kip P. Conner, Kevin D. Cook, Ana R. Correia, Andrew Dykstra, Sudipa Ghimire-Rijal, Kevin Graham, Peter Grandsard, Joon Huh, John O. Hui, Mani Jain, Victoria Jann, Lei Jia, Sheree Johnstone, Neelam Khanal, Carl Kolvenbach, Linda Narhi, Rupa Padaki, Emma M. Pelegri-O’Day, Wei Qi, Vladimir Razinkov, Austin J. Rice, Richard Smith, Christopher Spahr, Jennitte Stevens, Yax Sun, Veena A. Thomas, Sarah van Driesche, Robert Vernon, Victoria Wagner, Kenneth W. Walker, Yangjie Wei, Dwight Winters, Melissa Yang & Iain D. G. Campuzano. (2023) Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodies. mAbs 15:1.
Read now
Read now
Romain Ollier, Aline Fuchs, Florence Gauye, Katarzyna Piorkowska, Sébastien Menant, Monisha Ratnam, Paolo Montanari, Florence Guilhot, Didier Phillipe, Mickael Audrain, Anne-Laure Egesipe, Damien Névoltris, Tamara Seredenina, Andrea Pfeifer, Marie Kosco-Vilbois & Tariq Afroz. (2023) Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human framework. mAbs 15:1.
Read now
Read now
Monica L. Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif T. Gjølberg, Timothy P. Jenkins, Bjørn Gunnar Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus R. Liedl, Peter M. Tessier, John McCafferty & Andreas H. Laustsen. (2023) Assessing developability early in the discovery process for novel biologics. mAbs 15:1.
Read now
Read now
Hristo L. Svilenov, Paolo Arosio, Tim Menzen, Peter Tessier & Pietro Sormanni. (2023) Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties. mAbs 15:1.
Read now
Read now
Samantha Phan, Auralee Walmer, Eudean W. Shaw & Qing Chai. (2022) High-throughput profiling of antibody self-association in multiple formulation conditions by PEG stabilized self-interaction nanoparticle spectroscopy. mAbs 14:1.
Read now
Read now
Rahmad Akbar, Habib Bashour, Puneet Rawat, Philippe A. Robert, Eva Smorodina, Tudor-Stefan Cotet, Karine Flem-Karlsen, Robert Frank, Brij Bhushan Mehta, Mai Ha Vu, Talip Zengin, Jose Gutierrez-Marcos, Fridtjof Lund-Johansen, Jan Terje Andersen & Victor Greiff. (2022) Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies. mAbs 14:1.
Read now
Read now
Rachel H. Rose, Armin Sepp, Felix Stader, Katherine L. Gill, Cong Liu & Iain Gardner. (2022) Application of physiologically based pharmacokinetic models for therapeutic proteins and other novel modalities. Xenobiotica 52:8, pages 840-854.
Read now
Read now
Emily K. Makowski, Lina Wu, Alec A. Desai & Peter M. Tessier. (2021) Highly sensitive detection of antibody nonspecific interactions using flow cytometry. mAbs 13:1.
Read now
Read now
Boris Grinshpun, Nels Thorsteinson, Joao NS Pereira, Friedrich Rippmann, David Nannemann, Vanita D. Sood & Yves Fomekong Nanfack. (2021) Identifying biophysical assays and in silico properties that enrich for slow clearance in clinical-stage therapeutic antibodies. mAbs 13:1.
Read now
Read now
Emily K. Makowski, Lina Wu, Priyanka Gupta & Peter M. Tessier. (2021) Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods. mAbs 13:1.
Read now
Read now
Sharon M. Campbell, Joseph DeBartolo, James R. Apgar, Lydia Mosyak, Virginie McManus, Sonia Beyer, Eric M. Bennett, Matthew Lambert & Orla Cunningham. (2021) Combining random mutagenesis, structure-guided design and next-generation sequencing to mitigate polyreactivity of an anti-IL-21R antibody. mAbs 13:1.
Read now
Read now
Marie R.G. Kopp, Adriana-Michelle Wolf Pérez, Marta Virginia Zucca, Umberto Capasso Palmiero, Brigitte Friedrichsen, Nikolai Lorenzen & Paolo Arosio. (2020) An accelerated surface-mediated stress assay of antibody instability for developability studies. mAbs 12:1.
Read now
Read now
Marc Bailly, Carl Mieczkowski, Veronica Juan, Essam Metwally, Daniela Tomazela, Jeanne Baker, Makiko Uchida, Ester Kofman, Fahimeh Raoufi, Soha Motlagh, Yao Yu, Jihea Park, Smita Raghava, John Welsh, Michael Rauscher, Gopalan Raghunathan, Mark Hsieh, Yi-Ling Chen, Hang Thu Nguyen, Nhung Nguyen, Dan Cipriano & Laurence Fayadat-Dilman. (2020) Predicting Antibody Developability Profiles Through Early Stage Discovery Screening. mAbs 12:1.
Read now
Read now
Adriana-Michelle Wolf Pérez, Pietro Sormanni, Jonathan Sonne Andersen, Laila Ismail Sakhnini, Ileana Rodriguez-Leon, Jais Rose Bjelke, Annette Juhl Gajhede, Leonardo De Maria, Daniel E. Otzen, Michele Vendruscolo & Nikolai Lorenzen. (2019) In vitro and in silico assessment of the developability of a designed monoclonal antibody library. mAbs 11:2, pages 388-400.
Read now
Read now
Yingda Xu, Dongdong Wang, Bruce Mason, Tony Rossomando, Ning Li, Dingjiang Liu, Jason K Cheung, Wei Xu, Smita Raghava, Amit Katiyar, Christine Nowak, Tao Xiang, Diane D. Dong, Joanne Sun, Alain Beck & Hongcheng Liu. (2019) Structure, heterogeneity and developability assessment of therapeutic antibodies. mAbs 11:2, pages 239-264.
Read now
Read now
Lindsay B. Avery, Jason Wade, Mengmeng Wang, Amy Tam, Amy King, Nicole Piche-Nicholas, Mania S. Kavosi, Steve Penn, David Cirelli, Jeffrey C. Kurz, Minlei Zhang, Orla Cunningham, Rhys Jones, Brian J. Fennell, Barry McDonnell, Paul Sakorafas, James Apgar, William J. Finlay, Laura Lin, Laird Bloom & Denise M. O'Hara. (2018) Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics. mAbs 10:2, pages 244-255.
Read now
Read now
Ryan L. Kelly, James C. Geoghegan, Jared Feldman, Tushar Jain, Monique Kauke, Doris Le, Jessie Zhao & K. Dane Wittrup. (2017) Chaperone proteins as single component reagents to assess antibody nonspecificity. mAbs 9:7, pages 1036-1040.
Read now
Read now
Ryan L. Kelly, Jessie Zhao, Doris Le & K. Dane Wittrup. (2017) Nonspecificity in a nonimmune human scFv repertoire. mAbs 9:7, pages 1029-1035.
Read now
Read now
Miroslav Dostalek, Thomayant Prueksaritanont & Robert F. Kelley. (2017) Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidates. mAbs 9:5, pages 756-766.
Read now
Read now
Arvind Sivasubramanian, Patricia Estep, Heather Lynaugh, Yao Yu, Adam Miles, Josh Eckman, Kevin Schutz, Crystal Piffath, Nadthakarn Boland, Rebecca Hurley Niles, Stéphanie Durand, Todd Boland, Maximiliano Vásquez, Yingda Xu & Yasmina Abdiche. (2017) Broad epitope coverage of a human in vitro antibody library. mAbs 9:1, pages 29-42.
Read now
Read now
Ryan L. Kelly, Yao Yu, Tingwan Sun, Isabelle Caffry, Heather Lynaugh, Michael Brown, Tushar Jain, Yingda Xu & K. Dane Wittrup. (2016) Target-independent variable region mediated effects on antibody clearance can be FcRn independent. mAbs 8:7, pages 1269-1275.
Read now
Read now
Lindsay B. Avery, Mengmeng Wang, Mania S. Kavosi, Alison Joyce, Jeffrey C. Kurz, Yao-Yun Fan, Martin E. Dowty, Minlei Zhang, Yiqun Zhang, Aili Cheng, Fei Hua, Hannah M. Jones, Hendrik Neubert, Robert J. Polzer & Denise M. O'Hara. (2016) Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodies. mAbs 8:6, pages 1064-1078.
Read now
Read now
Articles from other publishers (40)
Ariel Tennenhouse, Lev Khmelnitsky, Razi Khalaila, Noa Yeshaya, Ashish Noronha, Moshit Lindzen, Emily K. Makowski, Ira Zaretsky, Yael Fridmann Sirkis, Yael Galon-Wolfenson, Peter M. Tessier, Jakub Abramson, Yosef Yarden, Deborah Fass & Sarel J. Fleishman. (2023) Computational optimization of antibody humanness and stability by systematic energy-based ranking. Nature Biomedical Engineering.
Crossref
Crossref
Tanja Ziegengeist, Jennifer Orth, Katja Kroll, Marion Schneider, Nadja Spindler, Dilyana Dimova, Severin Handschuh, Arnd Brandenburg, Reto Ossola, Norbert Furtmann, Joerg Birkenfeld, Christian Beil, Dietmar Hoffmann, Thorsten Schmidt, Rebecca Sendak, Melanie Fischer, Soraya Hölper & Jennifer Kühn. (2023) High-Throughput and Format-Agnostic Mispairing Assay for Multispecific Antibodies Using Intact Mass Spectrometry. Analytical Chemistry 95:27, pages 10265-10278.
Crossref
Crossref
Nicole SibandaRamesh Kumar ShanmugamRobin Curtis. (2023) The Relationship between Protein–Protein Interactions and Liquid–Liquid Phase Separation for Monoclonal Antibodies. Molecular Pharmaceutics 20:5, pages 2662-2674.
Crossref
Crossref
Shufang Liu & Dhaval K. Shah. (2023) Physiologically Based Pharmacokinetic Modeling to Characterize the Effect of Molecular Charge on Whole-Body Disposition of Monoclonal Antibodies. The AAPS Journal 25:3.
Crossref
Crossref
Pramodkumar P. Gupta, Mala M. Parab, Santosh S. Chhajed & Virupaksha A. Bastikar. 2023. Protein-based Therapeutics. Protein-based Therapeutics
275
296
.
Edward P. Harvey, Jung-Eun Shin, Meredith A. Skiba, Genevieve R. Nemeth, Joseph D. Hurley, Alon Wellner, Ada Y. Shaw, Victor G. Miranda, Joseph K. Min, Chang C. Liu, Debora S. Marks & Andrew C. Kruse. (2022) An in silico method to assess antibody fragment polyreactivity. Nature Communications 13:1.
Crossref
Crossref
Hannes Ausserwöger, Matthias M. Schneider, Therese W. Herling, Paolo Arosio, Gaetano Invernizzi, Tuomas P. J. Knowles & Nikolai Lorenzen. (2022) Non-specificity as the sticky problem in therapeutic antibody development. Nature Reviews Chemistry 6:12, pages 844-861.
Crossref
Crossref
Adriana-Michelle Wolf Pérez, Nikolai Lorenzen, Michele Vendruscolo & Pietro Sormanni. 2022. Therapeutic Antibodies. Therapeutic Antibodies
57
113
.
Michael D. Raleigh, Nicola Beltraminelli, Stephanie Fallot, Mark G. LeSage, Amy Saykao, Paul R. Pentel, Steve Fuller, Thomas Thisted, Zuzanna Biesova, Stephen Horrigan, Darryl Sampey, Bin Zhou & Matthew W. Kalnik. (2021) Attenuating nicotine’s effects with high affinity human anti-nicotine monoclonal antibodies. PLOS ONE 16:7, pages e0254247.
Crossref
Crossref
Maxime Lecerf, Alexia Kanyavuz, Sofia Rossini & Jordan D. Dimitrov. (2021) Interaction of clinical-stage antibodies with heme predicts their physiochemical and binding qualities. Communications Biology 4:1.
Crossref
Crossref
Carl Mieczkowski, Alan Cheng, Thierry Fischmann, Mark Hsieh, Jeanne Baker, Makiko Uchida, Gopalan Raghunathan, Corey Strickland & Laurence Fayadat-Dilman. (2021) Characterization and Modeling of Reversible Antibody Self-Association Provide Insights into Behavior, Prediction, and Correction. Antibodies 10:1, pages 8.
Crossref
Crossref
Alec A. Desai, Matthew D. Smith, Yulei Zhang, Emily K. Makowski, Julia E. Gerson, Edward Ionescu, Charles G. Starr, Jennifer M. Zupancic, Shannon J. Moore, Alexandra B. Sutter, Magdalena I. Ivanova, Geoffrey G. Murphy, Henry L. Paulson & Peter M. Tessier. (2021) Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificity. Journal of Biological Chemistry 296, pages 100508.
Crossref
Crossref
Melissa A. Gray, Michal A. Stanczak, Natália R. Mantuano, Han Xiao, Johan F. A. Pijnenborg, Stacy A. Malaker, Caitlyn L. Miller, Payton A. Weidenbacher, Julia T. Tanzo, Green Ahn, Elliot C. Woods, Heinz Läubli & Carolyn R. Bertozzi. (2020) Targeted glycan degradation potentiates the anticancer immune response in vivo. Nature Chemical Biology 16:12, pages 1376-1384.
Crossref
Crossref
Christopher T Boughter, Marta T Borowska, Jenna J Guthmiller, Albert Bendelac, Patrick C Wilson, Benoit Roux & Erin J Adams. (2020) Biochemical patterns of antibody polyreactivity revealed through a bioinformatics-based analysis of CDR loops. eLife 9.
Crossref
Crossref
Micael Karlberg, João Victor de Souza, Lanyu Fan, Arathi Kizhedath, Agnieszka K. Bronowska & Jarka Glassey. (2020) QSAR Implementation for HIC Retention Time Prediction of mAbs Using Fab Structure: A Comparison between Structural Representations. International Journal of Molecular Sciences 21:21, pages 8037.
Crossref
Crossref
Manali S. Sawant, Craig N. Streu, Lina Wu & Peter M. Tessier. (2020) Toward Drug-Like Multispecific Antibodies by Design. International Journal of Molecular Sciences 21:20, pages 7496.
Crossref
Crossref
Steven A. Berkowitz. 2020. Biophysical Characterization of Proteins in Developing Biopharmaceuticals. Biophysical Characterization of Proteins in Developing Biopharmaceuticals
431
456
.
Priyanka Singh, Aisling Roche, Christopher F. van der Walle, Shahid Uddin, Jiali Du, Jim Warwicker, Alain Pluen & Robin Curtis. (2019) Determination of Protein–Protein Interactions in a Mixture of Two Monoclonal Antibodies. Molecular Pharmaceutics 16:12, pages 4775-4786.
Crossref
Crossref
Hannah M. Jones, Zhiwei Zhang, Paul Jasper, Haobin Luo, Lindsay B. Avery, Lindsay E. King, Hendrik Neubert, Hugh A. Barton, Alison M. Betts & Robert Webster. (2019)
A Physiologically‐Based Pharmacokinetic Model for the Prediction of Monoclonal Antibody Pharmacokinetics From
In Vitro
Data
. CPT: Pharmacometrics & Systems Pharmacology 8:10, pages 738-747.
Crossref
Crossref
Maxime Lecerf, Alexia Kanyavuz, Sébastien Lacroix-Desmazes & Jordan D. Dimitrov. (2019) Sequence features of variable region determining physicochemical properties and polyreactivity of therapeutic antibodies. Molecular Immunology 112, pages 338-346.
Crossref
Crossref
Arathi Kizhedath, Micael Karlberg & Jarka Glassey. (2019) Cross‐Interaction Chromatography‐Based QSAR Model for Early‐Stage Screening to Facilitate Enhanced Developability of Monoclonal Antibody Therapeutics. Biotechnology Journal 14:8, pages 1800696.
Crossref
Crossref
Wataru Aoki. 2019. Yeast Cell Surface Engineering. Yeast Cell Surface Engineering
123
147
.
Lilia A Rabia, Yulei Zhang, Seth D Ludwig, Mark C Julian & Peter M Tessier. (2018) Net charge of antibody complementarity-determining regions is a key predictor of specificity. Protein Engineering, Design and Selection 31:11, pages 409-418.
Crossref
Crossref
Li Zhou, Jun Zhang, Enrico DiGiammarino, Amol Kavishwar, Bo Yan, Chris Chumsae, Peter M. Ihnat, David Powers, John Harlan & William Blaine Stine. (2018) PULSE SPR: A High Throughput Method to Evaluate the Domain Stability of Antibodies. Analytical Chemistry 90:20, pages 12221-12229.
Crossref
Crossref
Lilia A. Rabia, Alec A. Desai, Harkamal S. Jhajj & Peter M. Tessier. (2018) Understanding and overcoming trade-offs between antibody affinity, specificity, stability and solubility. Biochemical Engineering Journal 137, pages 365-374.
Crossref
Crossref
Marie R.G. Kopp & Paolo Arosio. (2018) Microfluidic Approaches for the Characterization of Therapeutic Proteins. Journal of Pharmaceutical Sciences 107:5, pages 1228-1236.
Crossref
Crossref
Algirdas Grevys, Jeannette Nilsen, Kine M. K. Sand, Muluneh B. Daba, Inger Øynebråten, Malin Bern, Martin B. McAdam, Stian Foss, Tilman Schlothauer, Terje E. Michaelsen, Gregory J. Christianson, Derry C. Roopenian, Richard S. Blumberg, Inger Sandlie & Jan Terje Andersen. (2018) A human endothelial cell-based recycling assay for screening of FcRn targeted molecules. Nature Communications 9:1.
Crossref
Crossref
Ryan L. Kelly, Doris Le, Jessie Zhao & K. Dane Wittrup. (2018) Reduction of Nonspecificity Motifs in Synthetic Antibody Libraries. Journal of Molecular Biology 430:1, pages 119-130.
Crossref
Crossref
Mark C. Manning, Jun Liu, Tiansheng Li & Ryan E. Holcomb. 2018. Therapeutic Proteins and Peptides. Therapeutic Proteins and Peptides
1
59
.
Liming Liu. (2017) Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins. Protein & Cell 9:1, pages 15-32.
Crossref
Crossref
Tushar Jain, Todd Boland, Asparouh Lilov, Irina Burnina, Michael Brown, Yingda Xu & Maximiliano Vásquez. (2017) Prediction of delayed retention of antibodies in hydrophobic interaction chromatography from sequence using machine learning. Bioinformatics 33:23, pages 3758-3766.
Crossref
Crossref
Martin Klinger. (2017) A role for macromolecular crowding in off-target binding of therapeutic antibodies. Protein Engineering, Design and Selection 30:7, pages 489-494.
Crossref
Crossref
Cornelius Cilliers, Ian Nessler, Nikolas Christodolu & Greg M. Thurber. (2017) Tracking Antibody Distribution with Near-Infrared Fluorescent Dyes: Impact of Dye Structure and Degree of Labeling on Plasma Clearance. Molecular Pharmaceutics 14:5, pages 1623-1633.
Crossref
Crossref
Tushar JainTingwan SunStéphanie DurandAmy HallNga Rewa HoustonJuergen H. Nett, Beth Sharkey, Beata Bobrowicz, Isabelle CaffryYao YuYuan CaoHeather LynaughMichael BrownHemanta BaruahLaura T. GrayEric M. KraulandYingda XuMaximiliano VásquezK. Dane Wittrup. (2017) Biophysical properties of the clinical-stage antibody landscape. Proceedings of the National Academy of Sciences 114:5, pages 944-949.
Crossref
Crossref
Morgan S. A. GilmanCarlos A. CastellanosMan ChenJoan O. NgwutaEileen GoodwinSyed M. MoinVicente MasJosé A. MeleroPeter F. WrightBarney S. GrahamJason S. McLellanLaura M. Walker. (2016) Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors. Science Immunology 1:6.
Crossref
Crossref
Claire L. Dobson, Paul W. A. Devine, Jonathan J. Phillips, Daniel R. Higazi, Christopher Lloyd, Bojana Popovic, Joanne Arnold, Andrew Buchanan, Arthur Lewis, Joanne Goodman, Christopher F. van der Walle, Peter Thornton, Lisa Vinall, David Lowne, Anna Aagaard, Lise-Lotte Olsson, Anna Ridderstad Wollberg, Fraser Welsh, Theodoros K. Karamanos, Clare L. Pashley, Matthew G. Iadanza, Neil A. Ranson, Alison E. Ashcroft, Alistair D. Kippen, Tristan J. Vaughan, Sheena E. Radford & David C. Lowe. (2016) Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo. Scientific Reports 6:1.
Crossref
Crossref
Steven B. Geng, Jiemin Wu, Magfur E. Alam, Jason S. Schultz, Craig D. Dickinson, Carly R. Seminer & Peter M. Tessier. (2016) Facile Preparation of Stable Antibody–Gold Conjugates and Application to Affinity-Capture Self-Interaction Nanoparticle Spectroscopy. Bioconjugate Chemistry 27:10, pages 2287-2300.
Crossref
Crossref
Joseph G. Jardine, Devin Sok, Jean-Philippe Julien, Bryan Briney, Anita Sarkar, Chi-Hui Liang, Erin A. Scherer, Carole J. Henry Dunand, Yumiko Adachi, Devan Diwanji, Jessica Hsueh, Meaghan Jones, Oleksandr Kalyuzhniy, Michael Kubitz, Skye Spencer, Matthias Pauthner, Karen L. Saye-Francisco, Fabian Sesterhenn, Patrick C. Wilson, Denise M. Galloway, Robyn L. Stanfield, Ian A. Wilson, Dennis R. Burton & William R. Schief. (2016) Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design. PLOS Pathogens 12:8, pages e1005815.
Crossref
Crossref
Liang Zhang, Sumit Bhatnagar, Emily Deschenes & Greg M. Thurber. (2016) Mechanistic and quantitative insight into cell surface targeted molecular imaging agent design. Scientific Reports 6:1.
Crossref
Crossref
Steven B. Geng, Michael Wittekind, Adam Vigil & Peter M. Tessier. (2016) Measurements of Monoclonal Antibody Self-Association Are Correlated with Complex Biophysical Properties. Molecular Pharmaceutics 13:5, pages 1636-1645.
Crossref
Crossref